Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin esomeprazole chemoprevention trial in Barrett's oesophagus
ISRCTN85156844Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 3, randomised trial of esomeprazole and aspirin in Barrett's esophagus (4 arms), sponsored by University of Oxford. Primary endpoints: Composite of all-cause mortality, oesophageal adenocarcinoma, and high-grade dysplasia, Conversion to oesophageal adenocarcinoma and 2 more. Started Mar 2005; status: completed.
02
Drugs
esomeprazoleaspirin
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on ISRCTN85156844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN85156844.